Aurobindo Pharma to Acquire Remaining 49% Stake in Subsidiary GLS Pharma for INR 22.5 Crores

Aurobindo Pharma Ltd. has entered into a binding agreement to acquire the remaining 49% equity shares in its subsidiary, GLS Pharma Limited, for a purchase consideration of INR 22.5 crores. GLS Pharma Limited is a pharmaceutical company engaged in the business of Oncology products, with a total sales of INR 32.99 crores during FY 23-24. Post-acquisition, GLS will become a wholly owned subsidiary of Aurobindo Pharma Ltd. The acquisition is expected to strengthen Aurobindo Pharma's presence in the pharmaceutical industry.